Pancreatic cancer remains one of the deadliest malignancies, due in large part to challenges with early diagnosis.  Advanced ...

PanCAN has always led the way and our bold campaign is no different. It comes at an extraordinary time in pancreatic cancer ...

Around 11,500 people are diagnosed with pancreatic cancer in Britain each year, but the disease is notoriously hard to treat ...

The review offers important insights for patients and families by explaining why pancreatic cancer has proven so resistant to ...

An international team of scientists has created a three-dimensional (3D) pancreatic cancer tumor model in the laboratory, combining a bioengineered matrix and patient-derived cells that could ...

New research shows that the same genes are active in pancreatic cancer, obesity and diabetes, helping to explain why people ...

Researchers at Cold Spring Harbor Laboratory have discovered a way to target proteins in human cells that lead to pancreatic tumors, findings that show promise toward early treatment and possible ...

Pancreatic cancer can remain quiet for years, developing undetected before causing symptoms that lead to a diagnosis. Even ...

TTFields therapy concomitant with gemcitabine and nab-paclitaxel is the first treatment to show a clinically meaningful and statistically significant improvement in overall survival (OS) for patients ...

New research shows that the same genes are active in pancreatic cancer, obesity and diabetes, helping to explain why people ...

A laboratory on Long Island has found a breakthrough in the fight against pancreatic cancer that can “intercept” its spread. Now Amy Pollaci, whose father Bill Reindl was diagnosed with stage 4 ...

Add Yahoo as a preferred source to see more of our stories on Google. A laboratory on Long Island has found a breakthrough in the fight against pancreatic cancer that can “intercept” its spread. Now ...